Biotech boom ahead in 2024, top Jefferies analyst predicts on heels of Bristol Meyers-Karuna deal Published 2023-12-22 Download video MP4 360p Recommendations 24:10 How China May Soon Lead the Bio-Revolution 05:58 We see Big Pharma going after smaller biotechs in 2024, says Jefferies' Michael Yee 09:05 Bristol-Myers CEO Says the Company Is in Transition 12:48 Bitcoin prices recover after retreating from new record: CNBC Crypto World 07:13 OpenAI fires back at Elon Musk: Here's what you need to know 07:31 Watch what happens once Tesla starts selling cars for $25,000, says billionaire investor Ron Baron 04:22 There's a lot of money to be made in clean energy, says NorthStar's Nimrit Kang 05:19 Cramer: This biotech stock could be worth over $100 billion on an FDA approval 02:16 Weak data pushes yields lower 03:55 The AI party has already begun, says Wedbush Securities' Dan Ives 08:10 CNBC's 'Halftime Report' investment committee react to the New York Community Bank capital raise 01:28 Weekly mortgage demand surges 11% 05:45 All of the 'Mag 7' stocks look overpriced, says NYU's Aswath Damodaran 03:23 New York Community Bancorp halted for trading 03:45 Удар в Одесі біля Зеленського і прем'єра Греції – дайджест Несеться